NCT06548607 Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT06534177 Digital Diagnostics and Intervention Services for Parkinson's Disease Status NOT_YET_RECRUITING Phase N/A
NCT06507800 Cancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease iNdiCation trEated in FRance and Canada? Status NOT_YET_RECRUITING Phase N/A
NCT06503224 An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases Status RECRUITING Phase NA
NCT06499233 Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease Status RECRUITING Phase PHASE4
NCT06491979 Vitamin and Unsaturated Fatty Acid Supplements in Healthy and Uveitis Human Subjects Status COMPLETED Phase NA
NCT06470412 Personalized Management of Autoimmune Diseases With AI-Guided (GenAIS TM) Dietary Supplementation Status COMPLETED Phase NA
NCT06464679 An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases Status RECRUITING Phase PHASE1
NCT06435897 Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells Status RECRUITING Phase PHASE1/PHASE2
NCT06435468 Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases Status RECRUITING Phase NA
NCT06428188 Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases Status RECRUITING Phase PHASE1/PHASE2
NCT06426316 The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. Status RECRUITING Phase NA
NCT06417502 Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry Status RECRUITING Phase N/A
NCT06416267 Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL) Status NOT_YET_RECRUITING Phase N/A
NCT06413511 A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease Status WITHDRAWN Phase PHASE1
NCT06382675 Clinical Performance of the New Plasma Filter PX2 in TPE Treatments Status RECRUITING Phase NA
NCT06375993 A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease Status ENROLLING_BY_INVITATION Phase PHASE1